Page last updated: 2024-09-03

umifenovir and Catarrh

umifenovir has been researched along with Catarrh in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bulgakova, VA; Grekova, AI; Leneva, IA; Lvov, NI; Maleev, VV; Poromov, AA; Pshenichnaya, NY; Selkova, EP; Shestakova, IV1
Deeva, EG; Kiselev, OI; Kulikova, EV; Leneva, IA; Maleev, VV; Nadorov, SA; Obukhov, AA; Osipova, EA; Selkova, EP1

Trials

2 trial(s) available for umifenovir and Catarrh

ArticleYear
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).
    Terapevticheskii arkhiv, 2019, Mar-30, Volume: 91, Issue:3

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Common Cold; Double-Blind Method; Female; Humans; Indoles; Influenza, Human; Male; Middle Aged; Respiratory Tract Infections; Russia; Severity of Illness Index; Treatment Outcome; Young Adult

2019
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR].
    Terapevticheskii arkhiv, 2015, Volume: 87, Issue:1

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Common Cold; Double-Blind Method; Female; Humans; Indoles; Influenza, Human; Male; Middle Aged; RNA, Viral; Russia; Severity of Illness Index; Treatment Outcome; Young Adult

2015